Outcomes Research, United BioSource Corporation, 26-28 Hammersmith Grove, Floor 5E, London, W6 7HA, United Kingdom.
Health Qual Life Outcomes. 2012 Jun 12;10:65. doi: 10.1186/1477-7525-10-65.
To estimate utility values for different levels of migraine pain severity from a United Kingdom (UK) sample of migraineurs.
One hundred and six migraineurs completed the EQ-5D to evaluate their health status for mild, moderate and severe levels of migraine pain severity for a recent migraine attack, and for current health defined as health status within seven days post-migraine attack. Statistical tests were used to evaluate differences in mean utility scores by migraine severity.
Utility scores for each health state were significantly different from 1.0 (no problems on any EQ-5D dimension) (p < 0.0001) and one another (p < 0.0001). The lowest mean utility, - 0.20 (95% confidence interval [CI]: -0.27 - -0.13), was for severe migraine pain. The smallest difference in mean utility was between mild and moderate migraine pain (0.13) and the largest difference in mean utility was between current health (without migraine) and severe migraine pain (1.07).
Results indicate that all levels of migraine pain are associated with significantly reduced utility values. As severity worsened, utility decreased and severe migraine pain was considered a health state worse than death. Results can be used in cost-utility models examining the relative economic value of therapeutic strategies for migraine in the UK.
从英国偏头痛患者样本中估计不同偏头痛疼痛严重程度水平的效用值。
106 名偏头痛患者完成了 EQ-5D 评估,以评估他们在最近的偏头痛发作中处于轻度、中度和重度偏头痛疼痛严重程度水平的健康状况,以及当前健康状况(定义为偏头痛发作后七天内的健康状况)。使用统计检验来评估偏头痛严重程度不同的平均效用得分的差异。
每个健康状况的效用得分与 1.0(EQ-5D 维度无任何问题)显著不同(p<0.0001),彼此之间也显著不同(p<0.0001)。最低的平均效用为 - 0.20(95%置信区间 [CI]:-0.27 - -0.13),发生在严重偏头痛疼痛时。平均效用的最小差异发生在轻度和中度偏头痛疼痛之间(0.13),最大差异发生在当前健康(无偏头痛)和严重偏头痛疼痛之间(1.07)。
结果表明,所有程度的偏头痛疼痛都与显著降低的效用值相关。随着严重程度的恶化,效用值降低,严重偏头痛疼痛被认为是一种比死亡更糟糕的健康状况。研究结果可用于在英国考察偏头痛治疗策略的相对经济价值的成本效用模型。